Excelsior Biopharma (6496) — Free Cash Flow Generation Index
Excelsior Biopharma (6496) has a Free Cash Flow Generation Index of -2.80x as of June 2025. Free cash flow of NT$-10.64 Million represents -3% of operating cash flow (NT$3.80 Million). Explore 6496 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Excelsior Biopharma Free Cash Flow Generation Index (2017–2022)
Historical FCF Generation Index trend for Excelsior Biopharma across 5 annual periods. For the full cash flow conversion analysis, see Excelsior Biopharma (6496) cash conversion ratio.
Annual Free Cash Flow Generation for Excelsior Biopharma (2017–2022)
Year-by-year Free Cash Flow Generation Index for Excelsior Biopharma. Check Excelsior Biopharma total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | -0.42x | NT$-2.30 Million | NT$5.49 Million | NT$7.78 Million | ▼ -144.1% |
| 2021 | 0.95x | NT$52.95 Million | NT$55.82 Million | NT$2.88 Million | ▼ -3.0% |
| 2020 | 0.98x | NT$509.20 Million | NT$520.81 Million | NT$11.62 Million | ▲ +5.7% |
| 2018 | 0.92x | NT$117.38 Million | NT$126.92 Million | NT$9.54 Million | ▼ -2.4% |
| 2017 | 0.95x | NT$331.23 Million | NT$349.47 Million | NT$18.10 Million | — |